![]() |
市場調查報告書
商品編碼
2059063
糖尿病食品市場預測至2034年-按產品類型、營養特性、功能、飲食類型和最終用戶分類的全球分析Diabetic-Friendly Food Products Market Forecasts to 2034 - Global Analysis By Product Type, Nutritional Focus, Functional Benefit, Meal Type, and End User |
||||||
據 Stratistics MRC 稱,到 2026 年,全球糖尿病患者食品市場規模將達到 245 億美元,預計在預測期內將以 9.3% 的複合年成長率成長,到 2034 年將達到 499 億美元。
糖尿病食品是指專為幫助糖尿病或糖尿病前期患者控制血糖值和維持均衡飲食而特別配製的食品和飲料。這些產品通常採用低升糖指數成分,減少糖分、膳食纖維、健康脂肪和碳水化合物的攝取。代表性產品包括零食、烘焙食品、乳製品替代品、飲料和代餐食品。製造商也會添加糖替代品和促進代謝健康的成分。全球糖尿病盛行率的不斷上升以及消費者對預防性營養日益成長的關注,正在推動糖尿病食品領域的創新發展。
全球糖尿病盛行率正在上升。
久坐不動的生活方式和不健康的飲食習慣正導致全球糖尿病盛行率持續上升。這導致全球市場對糖尿病食品的需求顯著成長。消費者越來越關注血糖值管理和長期代謝健康風險。這種轉變推動了機能性食品的普及。醫療保健系統也正在推廣糖尿病預防性飲食干預措施。食品生產商正在開發專門的創新產品以滿足這些需求。
昂貴的專用原料
糖尿病患者產品中使用的特殊原料高成本,為市場帶來了挑戰。低升糖指數(GI)甜味劑和功能性膳食纖維等原料顯著增加了生產成本,導致零售價格高於傳統食品。新興市場消費者對價格的敏感度限制了產品的市場滲透。此外,高昂的產品研發成本也對製造商的利潤率帶來了壓力。供應鏈的限制進一步加劇了價格波動。
針對糖尿病的個人化營養方案
數位健康和營養管理技術的進步使得為每位糖尿病患者提供個人化飲食建議成為可能。這推動了個人化糖尿病營養產品的開發。各公司正在整合以人工智慧為基礎的監測系統、生物辨識數據和臨床營養見解,以打造量身訂製的食品解決方案,進而改善血糖控制和長期代謝健康狀況。全球對個人化營養的需求正在成長。醫療保健專業人員正在支持個人化飲食干預。精準營養領域的創新正在迅速發展。這些趨勢正在擴大市場的潛力。
遵守嚴格的標籤規定
糖尿病患者使用的藥品必須符合嚴格的糖含量和健康聲明標準。不同國家和地區的法律規範各不相同,這進一步增加了複雜性。合規成本和漫長的核准時間加重了製造商的營運負擔。標籤錯誤可能導致罰款和聲譽損害。頻繁的監管更新也為產品開發帶來了更多不確定性。這些因素對市場構成重大威脅。
新冠疫情提高了人們對糖尿病等慢性疾病及其相關健康風險的認知。在此期間,消費者更加關注免疫力和代謝健康,這導致對糖尿病食品和機能性食品的需求增加。封鎖措施影響了人們的飲食習慣,並提高了居家營養管理的意識。電子商務通路保障了產品的穩定供應。疫情過後,注重健康的消費趨勢持續增強。
在預測期內,血糖值管理細分市場預計將佔據最大的市場佔有率。
預計在預測期內,血糖值管理產品將佔據最大的市場佔有率。這是因為這些產品被廣泛用於控制餐後血糖值。醫療機構對這類產品的推薦日益增多,以及人們對血糖控制意識的不斷提高,進一步推動了市場需求。由於其已被證實的功效,這些產品正被納入日常飲食中。零售和醫療通路產品供應的不斷擴大也鞏固了該領域的領先地位。配方方面的持續創新正在提升產品的效能。
預計在預測期內,甜點產品細分市場將呈現最高的複合年成長率。
在預測期內,甜點產品細分市場預計將呈現最高的成長率,這主要得益於消費者對更健康甜點替代品的需求不斷成長,這些替代品可以讓糖尿病患者在不顯著影響血糖值的情況下享用甜食。製造商正在推出口味和質地更佳的創新低糖和無糖甜點產品。人們對無負擔產品的主導需求正在推動其進一步普及。零售店供應量的增加提高了產品的可近性。烘焙和糖果甜點類別的產品創新正在快速推進。
在預測期內,北美預計將佔據最大的市場佔有率,這主要得益於美國和加拿大等國家糖尿病的高發生率以及民眾對血糖值管理的高度重視。該地區也受益於先進的醫療保健基礎設施和眾多機能性食品生產商的存在。消費者對經臨床驗證的營養產品表現出極高的接受度。零售和線上通路的廣泛覆蓋進一步推動了產品的普及。持續的產品創新鞏固了其市場領先地位。
在預測期內,亞太地區預計將呈現最高的複合年成長率,這主要得益於中國、印度、日本和韓國等國家健康意識的不斷提高。飲食習慣的改變和加工食品消費量的增加,推動了糖尿病患者對相關產品需求的成長。零售網路和電子商務平台的擴張提高了產品的供應量。政府的健康促進政策也提高了民眾對糖尿病的意識提升。可支配收入的增加也促進了機能性食品消費的成長。這些因素共同推動了該地區最快的成長。
According to Stratistics MRC, the Global Diabetic-Friendly Food Products Market is accounted for $24.5 billion in 2026 and is expected to reach $49.9 billion by 2034 growing at a CAGR of 9.3% during the forecast period. Diabetic-friendly food products are specially formulated foods and beverages designed to help manage blood glucose levels and support balanced nutrition for individuals with diabetes or prediabetes. These products typically feature low glycemic index ingredients, reduced sugar content, dietary fibers, healthy fats, and controlled carbohydrate levels. Common categories include snacks, bakery products, dairy alternatives, beverages, and meal replacements. Manufacturers also incorporate sugar substitutes and functional ingredients that promote metabolic health. Increasing global diabetes prevalence and consumer focus on preventive nutrition are significantly contributing to the growth of diabetic-friendly food innovations.
Increasing global diabetes prevalence
The global prevalence of diabetes is rising steadily due to sedentary lifestyles and poor dietary habits. This is significantly increasing demand for diabetic-friendly food products across global markets. Consumers are becoming more aware of blood glucose management and long-term metabolic health risks. This shift is encouraging adoption of functional foods designed for glycemic control. Healthcare systems are also promoting preventive dietary interventions for diabetes management. Food manufacturers are responding with specialized product innovations.
High specialized ingredient pricing
The market faces challenges due to the high cost of specialized ingredients used in diabetic-friendly formulations. Ingredients such as low-glycemic sweeteners and functional fibers significantly increase production costs. This results in higher retail prices compared to conventional food products. Price sensitivity among consumers in emerging economies limits widespread adoption. Manufacturers also face margin pressure due to cost-intensive formulation requirements. Supply chain constraints further contribute to pricing volatility.
Personalized diabetic nutrition development
Advances in digital health and nutrition tracking are enabling customized dietary recommendations for individuals with diabetes. This is driving personalized diabetic nutrition development as companies integrate AI-based monitoring systems, biometric data, and clinical nutrition insights to create tailored food solutions that improve blood glucose control and long-term metabolic health outcomes. Demand for individualized nutrition is increasing globally. Healthcare providers are supporting personalized dietary interventions. Innovation in precision nutrition is accelerating rapidly. These trends are expanding market potential.
Strict labeling compliance regulations
Diabetic-friendly products must meet rigorous standards for sugar content and health claims. Regulatory frameworks vary across different countries and regions, creating additional complexity. Compliance costs and approval timelines increase operational burdens for manufacturers. Mislabeling risks can lead to penalties and reputational damage. Frequent regulatory updates add further uncertainty to product development. These factors act as a key market threat.
The COVID-19 pandemic increased awareness of chronic diseases such as diabetes and related health risks. Consumers became more focused on immunity and metabolic health management during this period. This led to higher demand for diabetic-friendly and functional food products. Lockdowns influenced dietary habits and increased home-based nutrition awareness. E-commerce channels supported consistent product availability. Health-conscious consumption trends strengthened post-pandemic.
The blood glucose management segment is expected to be the largest during the forecast period
The blood glucose management segment is expected to account for the largest market share during the forecast period as these products are widely used for controlling post-meal glucose levels. Increasing medical recommendations and rising awareness of glycemic control are further strengthening demand. These products are integrated into daily diets due to their proven functional benefits. Expanding product availability across retail and healthcare channels is also supporting segment dominance. Continuous innovation in formulation is enhancing effectiveness.
The dessert products segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the dessert products segment is predicted to witness the highest growth rate due to rising consumer demand for healthier indulgence alternatives that allow diabetic individuals to enjoy sweet foods without affecting blood glucose levels significantly. Manufacturers are introducing innovative low-sugar and sugar-free dessert formulations with improved taste and texture. Increasing lifestyle-driven demand for guilt-free consumption is further supporting adoption. Expanding retail availability is improving accessibility. Product innovation in bakery and confectionery categories is accelerating rapidly.
During the forecast period, the North America region is expected to hold the largest market share owing to high diabetes prevalence and strong awareness of blood glucose management in countries such as the United States and Canada. The region also benefits from advanced healthcare infrastructure and strong presence of functional food manufacturers. Consumers are highly receptive to clinically supported nutritional products. Wide product availability across retail and online channels further strengthens adoption. Continuous product innovation supports market leadership.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR driven by growing health awareness in countries such as China, India, Japan, and South Korea. Changing dietary habits and increasing consumption of processed foods are contributing to higher demand for diabetic-friendly products. Expanding retail networks and e-commerce platforms are improving product accessibility. Government health initiatives are also promoting diabetes awareness. Rising disposable incomes support higher consumption of functional foods. These factors drive the fastest regional growth.
Key players in the market
Some of the key players in Diabetic-Friendly Food Products Market include Nestle S.A., Abbott Laboratories, Danone S.A., PepsiCo, Inc., General Mills, Inc., Kellogg Company, Mondelez International, Ingredion Incorporated, Cargill, Incorporated, Tate & Lyle plc, Simply Good Foods Company, Quest Nutrition LLC, Hormel Foods Corporation, Huel Ltd. and Arla Foods amba.
In September 2025, Hormel Foods expanded its Hormel Vital Care(TM) line with a new series of shelf-stable, diabetic-friendly purees and shakes. This system launch provides a "medically tailored" food solution for patients with dysphagia and diabetes, utilizing the company's patented stabilization technology to deliver consistent nutritional values and controlled sugar content in clinical and home-care settings.
In August 2024, Abbott and Medtronic announced a strategic partnership to integrate Abbott's world-leading continuous glucose sensing technology with Medtronic's automated insulin delivery systems. This collaborative initiative aims to create a "closed-loop" ecosystem where nutritional data and glycemic responses are tracked in real-time, allowing diabetic patients to manage their condition with unprecedented precision through a single integrated digital platform.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.